TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
TCL Archive Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer April 30, 2004
TCL Archive In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction August 21, 1981
